167 related articles for article (PubMed ID: 7872887)
1. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.
Meyer M; Koeppe RA; Frey KA; Foster NL; Kuhl DE
Arch Neurol; 1995 Mar; 52(3):314-7. PubMed ID: 7872887
[TBL] [Abstract][Full Text] [Related]
2. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
Groom GN; Junck L; Foster NL; Frey KA; Kuhl DE
J Nucl Med; 1995 Dec; 36(12):2207-10. PubMed ID: 8523106
[TBL] [Abstract][Full Text] [Related]
3. Decreased carbon-11-flumazenil binding in early Alzheimer's disease.
Pascual B; Prieto E; Arbizu J; Marti-Climent JM; Peñuelas I; Quincoces G; Zarauza R; Pappatà S; Masdeu JC
Brain; 2012 Sep; 135(Pt 9):2817-25. PubMed ID: 22961552
[TBL] [Abstract][Full Text] [Related]
4. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.
Henry TR; Frey KA; Sackellares JC; Gilman S; Koeppe RA; Brunberg JA; Ross DA; Berent S; Young AB; Kuhl DE
Neurology; 1993 Oct; 43(10):1998-2006. PubMed ID: 8413957
[TBL] [Abstract][Full Text] [Related]
5. PET measures of benzodiazepine receptors in progressive supranuclear palsy.
Foster NL; Minoshima S; Johanns J; Little R; Heumann ML; Kuhl DE; Gilman S
Neurology; 2000 May; 54(9):1768-73. PubMed ID: 10802782
[TBL] [Abstract][Full Text] [Related]
6. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
7. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.
Ohyama M; Senda M; Ishiwata K; Kitamura S; Mishina M; Ishii K; Toyama H; Oda K; Katayama Y
Ann Nucl Med; 1999 Oct; 13(5):309-15. PubMed ID: 10582800
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine-GABAA receptor binding during absence seizures.
Prevett MC; Lammertsma AA; Brooks DJ; Cunningham VJ; Fish DR; Duncan JS
Epilepsia; 1995 Jun; 36(6):592-9. PubMed ID: 7555973
[TBL] [Abstract][Full Text] [Related]
9. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
Hasler G; Nugent AC; Carlson PJ; Carson RE; Geraci M; Drevets WC
Arch Gen Psychiatry; 2008 Oct; 65(10):1166-75. PubMed ID: 18838633
[TBL] [Abstract][Full Text] [Related]
10. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.
Heiss WD; Grond M; Thiel A; Ghaemi M; Sobesky J; Rudolf J; Bauer B; Wienhard K
Stroke; 1998 Feb; 29(2):454-61. PubMed ID: 9472889
[TBL] [Abstract][Full Text] [Related]
11. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.
Richardson MP; Koepp MJ; Brooks DJ; Fish DR; Duncan JS
Ann Neurol; 1996 Aug; 40(2):188-98. PubMed ID: 8773600
[TBL] [Abstract][Full Text] [Related]
13. Imaging and epilepsy.
Duncan JS
Brain; 1997 Feb; 120 ( Pt 2)():339-77. PubMed ID: 9117380
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
[TBL] [Abstract][Full Text] [Related]
15. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter receptor imaging in Alzheimer's disease.
Sedvall G; Nybäck H; Farde L; Persson A
J Neural Transm Suppl; 1987; 24():43-8. PubMed ID: 2824693
[TBL] [Abstract][Full Text] [Related]
17. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
[TBL] [Abstract][Full Text] [Related]
18. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon.
Sette G; Baron JC; Young AR; Miyazawa H; Tillet I; Barré L; Travère JM; Derlon JM; MacKenzie ET
Stroke; 1993 Dec; 24(12):2046-57; discussion 2057-8. PubMed ID: 8248987
[TBL] [Abstract][Full Text] [Related]
19. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
[TBL] [Abstract][Full Text] [Related]
20. Different sensitivities to competitive inhibition of benzodiazepine receptor binding of 11C-iomazenil and 11C-flumazenil in rhesus monkey brain.
Inoue O; Hosoi R; Kobayashi K; Itoh T; Gee A; Suzuki K
Ann Nucl Med; 2001 Apr; 15(2):137-9. PubMed ID: 11448072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
